Clinical Cases in Pharmacology Clinical Cases  ·  Endocrinology, Diabetes and Metabolism I  ·  Calcium & Bone  ·  Hungry Bone Syndrome After Parathyroidectomy: How Aggressively to Replete
Endocrinology, Diabetes and Metabolism I, Case 0018 — Calcium & Bone

Hungry Bone Syndrome After Parathyroidectomy: How Aggressively to Replete

A single patient whose successful surgery immediately created a new, opposite problem. The disagreement is how aggressively to chase a calcium that's falling faster than the usual post-operative dip.

Abbreviations, terms, and other agents mentioned in this case IV — intravenous  ·  ALP — alkaline phosphatase
Presentation

Faina O., a 63-year-old woman, underwent parathyroidectomy yesterday for severe primary hyperparathyroidism that had gone undiagnosed for years, discovered only when a routine physical for a new job's insurance requirement flagged an incidentally elevated calcium. By the time she reached surgery her pre-operative PTH was 412 pg/mL and her alkaline phosphatase 312 U/L — two numbers that, taken together, describe a skeleton that had been demineralizing under unopposed parathyroid drive for a long stretch before anyone caught it. The operation itself went smoothly; a single adenoma was resected and confirmed on pathology, and her surgeon is confident the right gland came out.

What is happening now is the expected and occasionally severe flip side of a successful parathyroidectomy in a patient whose bone was that hormonally starved beforehand. The size of the drop already on record is the part worth reading closely. Her calcium has gone from 11.6 pre-operatively to 8.1 in six hours — three and a half milligrams in a single interval, before the bone's demand has had time to peak — and the alkaline phosphatase of 312 says that demand is coming from a resorption surface primed to reverse the moment the hormonal drive is withdrawn. That pairing of severely elevated pre-operative PTH and alkaline phosphatase is what the observational literature on hungry bone syndrome, from Brasier and Nussbaum's original characterization onward, converges on as the marker of the patients whose calcium falls fastest and furthest, rather than settling into the milder dip most patients experience. Her fingers have just started to tingle. That is not the syndrome arriving; it is the first reading on a curve that has not turned yet.

Faina O. · 63 Post-op day 0, parathyroidectomy
Pre-op PTH
412 pg/mL, severely elevated
Pre-op alkaline phosphatase
312 U/L, severely elevated
Current calcium
8.1 mg/dL, down from pre-op 11.6 mg/dL
Symptoms
New mild perioral and finger tingling, 6 hours post-op
Surgical outcome
Uncomplicated, single adenoma resected, confirmed on pathology
Renal function
eGFR 74 mL/min

How fast her bone is about to pull calcium in

Endocrine Surgeon Opening

I'd start aggressive IV calcium plus high-dose oral calcitriol now, before her calcium falls further. Her pre-operative PTH and alkaline phosphatase were both severely elevated, and the observational literature on hungry bone syndrome — Brasier and Nussbaum's original characterization of the syndrome after parathyroidectomy, and the predictor series that followed it — converges on exactly that pairing as what marks out the patients whose calcium falls fastest. Undertreating this specific drop risks tetany, seizure, or arrhythmia from a fall considerably faster and deeper than the routine post-op dip.

Endocrinologist Response

I'd be cautious about matching an aggressive fixed dose to her pre-operative severity alone. Bone hunger typically resolves within days to a couple of weeks, often faster than an aggressive regimen can be safely tapered — overcorrecting into hypercalcemia once her bone stops pulling calcium in is a real, avoidable risk.

I agree her markers predict a rapid, deep drop — I'm not arguing to undertreat her — I just don't think a fixed starting intensity, aggressive or otherwise, should be locked in without a clear plan to actively adjust it.

Hospitalist Final

I think you're both describing the same real risk from opposite ends. Her severity markers do argue for starting aggressively — that part isn't really in dispute — but the dose needs to be actively titrated against calcium checks every 4 to 6 hours over the next several days, not locked to either an aggressive or conservative starting point and left unadjusted.

That protocol catches both failure modes: it starts intensively enough to protect her from a rapid, severe drop given her known risk markers, and it re-checks often enough to pull back before an aggressive regimen overshoots once her bone hunger resolves.

Regimen selected
IV Calcium Gluconate
Calcium Repletion · Continuous infusion, titrated
Started aggressively given her severe pre-operative PTH/ALP predicting severe hungry bone syndrome; dose actively adjusted against calcium checks every 4–6 hours.
Calcitriol (high-dose)
Active Vitamin D Analog · Oral, started concurrently
Enhances intestinal calcium absorption to support the IV repletion; dose titrated alongside frequent lab monitoring.
Oral Calcium Carbonate
Calcium Supplement · High-dose, divided
Added to IV repletion as she tolerates oral intake, supporting the transition off IV calcium as bone hunger resolves.
Where this was left

Agreed: aggressive IV calcium and high-dose calcitriol started immediately given her severe pre-operative markers, with calcium rechecked every 4 to 6 hours and doses actively titrated rather than held fixed, explicitly to avoid both undertreatment now and overcorrection once bone hunger resolves.

Not fully settled: the exact calcium threshold that will trigger tapering the IV repletion toward an oral-only regimen — the team agreed on frequent reassessment but left the specific taper trigger to be determined once her actual trend over the first 24 to 48 hours is visible, rather than fixing a number in advance.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →